Advertisement

Topics

Real-World Data and Clinical Pharmacology: A Regulatory Science Perspective.

08:00 EDT 9th April 2019 | BioPortfolio

Summary of "Real-World Data and Clinical Pharmacology: A Regulatory Science Perspective."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Clinical pharmacology and therapeutics
ISSN: 1532-6535
Pages:

Links

DeepDyve research library

PubMed Articles [45808 Associated PubMed Articles listed on BioPortfolio]

Regulation and Innovation: Role of Regulatory Science in Facilitating Pharmaceutical Innovation.

Regulatory science is defined as science and research intended to inform decision making in a regulatory framework. This issue of Clinical Pharmacology & Therapeutics and the papers herein deal with t...

Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe.

The missing reality of real life in real-world evidence.

Reality is defined as a real event, a real thing or state of affairs. Reality exists in the places where we live our daily lives, in the relationships we have with others and in our experiences, circu...

Closing the Evidence Gap in Interstitial Lung Disease: The Promise of Real World Data.

The complexity of modern medicine generates an enormous number of clinical questions, resulting in an expanding evidence gap that cannot be addressed by traditional clinical trials alone. Simultaneous...

Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?

Clinical Trials [8305 Associated Clinical Trials listed on BioPortfolio]

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

The objective of this clinical trial is to examine the clinical pharmacology properties of TAK-233 in healthy female subjects

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, de...

Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace: Experiment 1

Tobacco regulatory policies can have unanticipated consequences; therefore, methods that would permit prospective estimates of the effects of potential tobacco regulations are necessary fo...

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

The primary objectives of this study is to estimate the real-world safety profile of Eliquis in Japanese Venous Thromboembolism patients and to estimate the risk factors likely to affect t...

Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

This is a local, prospective, non-interventional, regulatory postmarketing surveillance study. The objectives of this study are to assess the safety and efficacy of single agent Tagrisso (...

Medical and Biotech [MESH] Definitions

The science and art of collecting, summarizing, and analyzing data that are subject to random variation. The term is also applied to the data themselves and to the summarization of the data.

The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.

Works consisting of an announcement or statement of recent or current events of new data and matters of interest in the field of medicine or science. In some publications, such as "Nature" or "Science," the news reports are substantively written and herald medical and scientific data of vital or controversial importance.

The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))

Committees established to review interim data and efficacy outcomes in clinical trials. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the "Common Rule") require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article